Japan's Shionogi sells coronavirus drug rights to U.S. biotech BioAge
By Rocky SwiftTOKYO, Jan 26 (Reuters) - Japanese drugmaker Shionogi & Co said on Tuesday it has sold the development and marketing rights for a...
By Rocky SwiftTOKYO, Jan 26 (Reuters) - Japanese drugmaker Shionogi & Co said on Tuesday it has sold the development and marketing rights for a...